PAR-2 depletion protects against the development of pulmonary hypertension

被引：0
|
作者：
Wygrecka, Malgorzata
Markart, Philipp [1 ]
Marsh, Leigh M. [2 ]
Dahal, Bhola K. [1 ]
Schermuly, Ralph T. [1 ]
Taube, Christian [3 ]
Meinhardt, Andreas
Ghofrani, Ardeschir [1 ]
Steinhoff, Martin [4 ]
Seeger, Werner [1 ]
Preissner, Klaus T.
Weissmann, Norbert [1 ]
Kwapiszewska, Grazyna [1 ]
机构：
[1] Univ Giessen, Dept Internal Med, Lung Ctr, D-6300 Giessen, Germany
[2] Univ Marburg, Dept Clin Chem, D-3550 Marburg, Germany
[3] Johannes Gutenberg Univ Mainz, Med Clin 3, Mainz, Germany
[4] Univ Calif San Francisco, Dept Dermatol & Surg, San Francisco, CA 94143 USA
来源：
VASCULAR PHARMACOLOGY | 2012年 / 56卷 / 5-6期
关键词：
D O I：
10.1016/j.vph.2011.08.124
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [31] CONTINUOUS INHALATION OF NITRIC-OXIDE PROTECTS AGAINST DEVELOPMENT OF PULMONARY-HYPERTENSION IN CHRONICALLY HYPOXIC RATS
    KOUYOUMDJIAN, C
    ADNOT, S
    LEVAME, M
    EDDAHIBI, S
    BOUSBAA, H
    RAFFESTIN, B
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02): : 578 - 584
  • [32] CONTINUOUS INHALATION OF NITRIC-OXIDE PROTECTS AGAINST DEVELOPMENT OF PULMONARY-HYPERTENSION IN CHRONICALLY HYPOXIC RATS
    ADNOT, S
    KOUYOUMDJIAN, C
    EDDAHIBI, S
    RAFFESTIN, B
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A494 - A494
  • [33] Acid-Sensing Ion Channels (ASICs) 2 and 3 Buffer Pulmonary Vasoreactivity and ASIC2 Protects Against the Development of Chronic Hypoxia -Induced Pulmonary Hypertension
    Detweiler, Neil D.
    Vigil, Kenneth G.
    Yan, Simin
    Herbert, Lindsay M.
    Bennett, Michael C.
    Resta, Thomas C.
    Walker, Benjimen R.
    Jernigan, Nikki L.
    FASEB JOURNAL, 2018, 32 (01):
  • [34] Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation
    Carvalho, Ricardo Filipe da Silva
    Nilsson, Gunnar
    Harvima, Ilkka Tapani
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 117 - 122
  • [35] H2S releasing sodium sulfide protects against pulmonary hypertension by improving vascular responses in monocrotaline-induced pulmonary hypertension
    Turhan, Kumru
    Alan, Elif
    Yetik-Anacak, Gunay
    Sevin, Gulnur
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931
  • [36] PAR-1 and PAR-2 receptor mediated actions in the human intestine
    Mueller, K.
    Michel, K.
    Krueger, D.
    Demir, I. E.
    Ceyhan, G. O.
    Zeller, F.
    Kreis, M. E.
    Schemann, M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 : 16 - 16
  • [37] Chronic Exposure to Cigarette Smoke Induces Pulmonary Hypertension and Vascular Remodelling in Mice Over-Expressing Protease-Activated Receptor-2 (PAR-2).
    Lucattelli, M.
    De Cunto, G.
    Cardini, S.
    Lungarella, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [38] Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension
    Zhou, Xiaofei
    Jiang, Yuanqing
    Wang, Yuewen
    Fan, Linge
    Zhu, Yunhui
    Chen, Yefeng
    Wang, Yiran
    Zhu, Yingyi
    Wang, Hongkun
    Pan, Zihang
    Li, Zhoubin
    Zhu, Xiaolong
    Ren, Ruizhe
    Ge, Zhen
    Lai, Dongwu
    Lai, En Yin
    Chen, Ting
    Wang, Kai
    Liang, Ping
    Qin, Lingfeng
    Liu, Cuiqing
    Qiu, Cong
    Simons, Michael
    Yu, Luyang
    CIRCULATION RESEARCH, 2023, 133 (06) : 508 - 531
  • [39] Arginase inhibition protects against hypoxia-induced pulmonary arterial hypertension
    Jiang, Wenjin
    Sun, Bolin
    Song, Xuepeng
    Zheng, Yanbo
    Wang, Ligang
    Wang, Tao
    Liu, Sheng
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4743 - 4749
  • [40] Mitochondrial catalase expression protects against hypoxia-induced pulmonary hypertension
    Adesina, Sherry Eniola
    Hart, C. Michael
    Sutliff, Roy L.
    FASEB JOURNAL, 2013, 27
12345